Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Biosoftware, Sirs-Lab, BioTrove, Toray, Genetix, Gentel BioSurfaces, Honeywell

Premium

Rosetta Biosoftware has launched version 5.0 of the Rosetta Resolver gene expression data analysis system. New features include additional customization capabilities, a similarity search feature, and productivity enhancements.


Sirs-Lab has launched the Lab-Arraytor 60-inflammation biochip for gene expression studies. The chip contains 780 inflammation-specific genes, and is available with an introductory discount of 15 percent, valid until the end of the year.


BioTrove has launched the OpenArray Transcript Analysis system for high-density, quantitative PCR analyses. The new product allows researchers to study 9,000 transcripts simultaneously in about two hours.


Toray of Tokyo, has developed a new DNA chip that it claims is capable of up to 100 times the detection sensitivity of conventional DNA chips. The firm is considering a production plan for the chips this year.


Genetix has launched a new hybrid bed option to complement its medium-throughput QArray2 microarray platform. According to the firm, the new option allows users to array either into 16 microtiter plates or onto 32 conventional glass slides on the same instrument.


Gentel BioSurfaces has launched the PathT Protein Microarray Kit for biomarker discovery and protein profiling.


Honeywell introduced Honeywell Burdick & Jackson solvents, reagents and purification blends for solution and solid-phase peptide synthesis.

 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.